{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:35:27Z","timestamp":1777080927050,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-50-00060"],"award-info":[{"award-number":["14-50-00060"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00705-017-3492-0","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T10:01:04Z","timestamp":1501581664000},"page":"3355-3362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bioselection of coxsackievirus B6 strain variants with altered tropism to human cancer cell lines"],"prefix":"10.1007","volume":"162","author":[{"given":"Victor A.","family":"Svyatchenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir A.","family":"Ternovoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai N.","family":"Kiselev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna V.","family":"Demina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery B.","family":"Loktev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey V.","family":"Netesov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-2908","authenticated-orcid":false,"given":"Peter M.","family":"Chumakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"3492_CR1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.bjc.6604876","volume":"100","author":"M Anders","year":"2009","unstructured":"Anders M, Vieth M, Rocken C, Ebert M, Pross M, Gretschel S, Schlag PM, Wiedenmann B, Kemmner W, Hocker M (2009) Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. Br J Cancer 100:352\u2013359","journal-title":"Br J Cancer"},{"key":"3492_CR2","first-page":"1471","volume":"26","author":"GG Au","year":"2005","unstructured":"Au GG, Lindberg AM, Barry RD, Shafren DR (2005) Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21. Int J Oncol 26:1471\u20131476","journal-title":"Int J Oncol"},{"key":"3492_CR3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-422X-8-22","volume":"8","author":"GG Au","year":"2011","unstructured":"Au GG, Beagley LG, Haley ES, Barry RD, Shafren DR (2011) Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18. Virol J 8:22","journal-title":"Virol J"},{"key":"3492_CR4","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1128\/JVI.69.3.1903-1906.1995","volume":"69","author":"JM Bergelson","year":"1995","unstructured":"Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW (1995) Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69:1903\u20131906","journal-title":"J Virol"},{"key":"3492_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/pros.20741","volume":"68","author":"LJ Berry","year":"2008","unstructured":"Berry LJ, Au GG, Barry RD, Shafren DR (2008) Potent oncolytic activity of human enteroviruses against human prostate cancer. Prostate 68:577\u2013587","journal-title":"Prostate"},{"key":"3492_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1099\/0022-1317-32-2-295","volume":"32","author":"AC Chanas","year":"1976","unstructured":"Chanas AC, Johnson BK, Simpson DI (1976) Antigenic relationships of alphaviruses by a simple micro-culture cross-neutralization method. J Gen Virol 32:295\u2013300","journal-title":"J Gen Virol"},{"key":"3492_CR7","first-page":"37","volume":"11\u201312","author":"MP Chumakov","year":"1992","unstructured":"Chumakov MP, Voroshilova MK, Antsupova AS, Boiko VM, Blinova MI, Priimyagi LS, Rodin VI, Seibil VB, Sinyak KM, Smorodintsev AA, Stepanchuk VA, Terekhov SN, Trofimova LI, Chumakov PM (1992) Live enterovirus vaccines for the urgent nonspecific prevention of mass respiratory diseases during autumn and winter epidemics of influenza and acute respiratory diseses. J Microbiol Epidemiol Immunol (Rus) 11\u201312:37\u201340","journal-title":"J Microbiol Epidemiol Immunol (Rus)"},{"key":"3492_CR8","first-page":"712","volume":"46","author":"PM Chumakov","year":"2012","unstructured":"Chumakov PM, Morozova VV, Babkin IV, Baykov IK, Netesov SV, Tikunova NV (2012) Oncolytic enteroviruses. Mol Biol 46:712\u2013725","journal-title":"Mol Biol"},{"key":"3492_CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CMR.0000000000000180","volume":"25","author":"S Donina","year":"2015","unstructured":"Donina S, Strele I, Proboka G, Auzins J, Alberts P, Jonsson B, Venskus D, Muceniece A (2015) Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study. Melanoma Res 25:421\u2013426","journal-title":"Melanoma Res"},{"key":"3492_CR10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2217\/fvl.11.76","volume":"6","author":"C Goetz","year":"2011","unstructured":"Goetz C, Dobrikova E, Shveygert M, Dobrikov M, Gromeier M (2011) Oncolytic poliovirus against malignant glioma. Future Virol 6:1045\u20131058","journal-title":"Future Virol"},{"key":"3492_CR11","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1128\/JVI.02383-09","volume":"84","author":"M Gullberg","year":"2010","unstructured":"Gullberg M, Tolf C, Jonsson N, Polacek C, Precechtelova J, Badurova M, Sojka M, Mohlin C, Israelsson S, Johansson K, Bopegamage S, Hafenstein S, Lindberg AM (2010) A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells. J Virol 84:5868\u20135879","journal-title":"J Virol"},{"key":"3492_CR12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/1743-422X-8-473","volume":"8","author":"S Israelsson","year":"2011","unstructured":"Israelsson S, Jonsson N, Gullberg M, Lindberg AM (2011) Cytolytic replication of echoviruses in colon cancer cell lines. Virol J 8:473","journal-title":"Virol J"},{"key":"3492_CR13","doi-asserted-by":"crossref","first-page":"12603","DOI":"10.1128\/JVI.78.22.12603-12612.2004","volume":"78","author":"ES Johansson","year":"2004","unstructured":"Johansson ES, Xing L, Cheng RH, Shafren DR (2004) Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21. J Virol 78:12603\u201312612","journal-title":"J Virol"},{"key":"3492_CR14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","volume":"14","author":"HL Kaufman","year":"2015","unstructured":"Kaufman HL, Kohlhapp FJ, Zloza A (2015) Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov 14:642\u2013662","journal-title":"Nat Rev Drug Discov"},{"key":"3492_CR15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00109-016-1453-9","volume":"94","author":"BA Keller","year":"2016","unstructured":"Keller BA, Bell JC (2016) Oncolytic viruses-immunotherapeutics on the rise. J Mol Med (Berl) 94:979\u2013991","journal-title":"J Mol Med (Berl)"},{"key":"3492_CR16","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1038\/mto.2015.11","volume":"2","author":"OV Matveeva","year":"2015","unstructured":"Matveeva OV, Guo Z-S, Shabalina SV, Chumakov PM (2015) Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficacy. Mol Ther Oncol 2:15011","journal-title":"Mol Ther Oncol"},{"key":"3492_CR17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JVI.79.1.655-660.2005","volume":"79","author":"AM Milstone","year":"2005","unstructured":"Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM (2005) Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol 79:655\u2013660","journal-title":"J Virol"},{"key":"3492_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0022-1759(90)90309-J","volume":"130","author":"M Niks","year":"1990","unstructured":"Niks M, Otto M (1990) Towards an optimized MTT assay. J Immunol Methods 130:149\u2013151","journal-title":"J Immunol Methods"},{"key":"3492_CR19","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1128\/JVI.00503-11","volume":"85","author":"J Pan","year":"2011","unstructured":"Pan J, Narayanan B, Shah S, Yoder JD, Cifuente JO, Hafenstein S, Bergelson JM (2011) Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor. J Virol 85:7436\u20137443","journal-title":"J Virol"},{"key":"3492_CR20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virusres.2005.04.021","volume":"113","author":"C Polacek","year":"2005","unstructured":"Polacek C, Ekstrom JO, Lundgren A, Lindberg AM (2005) Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells. Virus Res 113:107\u2013115","journal-title":"Virus Res"},{"key":"3492_CR21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/JVI.49.3.635-640.1984","volume":"49","author":"KJ Reagan","year":"1984","unstructured":"Reagan KJ, Goldberg B, Crowell RL (1984) Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J Virol 49:635\u2013640","journal-title":"J Virol"},{"key":"3492_CR22","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1128\/JVI.71.6.4736-4743.1997","volume":"71","author":"DR Shafren","year":"1997","unstructured":"Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD (1997) Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 71:4736\u20134743","journal-title":"J Virol"},{"key":"3492_CR23","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1128\/JVI.72.11.9407-9412.1998","volume":"72","author":"DR Shafren","year":"1998","unstructured":"Shafren DR (1998) Viral cell entry induced by cross-linked decay-accelerating factor. J Virol 72:9407\u20139412","journal-title":"J Virol"},{"key":"3492_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1158\/1078-0432.CCR-0690-3","volume":"10","author":"DR Shafren","year":"2004","unstructured":"Shafren DR, Au GG, Nguyen T, Newcombe NG, Haley ES, Beagley L, Johansson ES, Hersey P, Barry RD (2004) Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21. Clin Cancer Res 10:53\u201360","journal-title":"Clin Cancer Res"},{"key":"3492_CR25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ijc.20866","volume":"115","author":"DR Shafren","year":"2005","unstructured":"Shafren DR, Sylvester D, Johansson ES, Campbell IG, Barry RD (2005) Oncolysis of human ovarian cancers by echovirus type 1. Int J Cancer 115:320\u2013328","journal-title":"Int J Cancer"},{"key":"3492_CR26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.virusres.2015.08.003","volume":"210","author":"T Smura","year":"2015","unstructured":"Smura T, Natri O, Ylipaasto P, Hellman M, Al-Hello H, Piemonti L, Roivainen M (2015) Enterovirus strain and type-specific differences in growth kinetics and virus-induced cell destruction in human pancreatic duct epithelial HPDE cells. Virus Res 210:188\u2013197","journal-title":"Virus Res"},{"key":"3492_CR27","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731\u20132739","journal-title":"Mol Biol Evol"},{"key":"3492_CR28","doi-asserted-by":"crossref","first-page":"9780","DOI":"10.1128\/JVI.77.18.9780-9789.2003","volume":"77","author":"N Verdaguer","year":"2003","unstructured":"Verdaguer N, Jimenez-Clavero MA, Fita I, Ley V (2003) Structure of swine vesicular disease virus: mapping of changes occurring during adaptation of human coxsackie B5 virus to infect swine. J Virol 77:9780\u20139789","journal-title":"J Virol"},{"key":"3492_CR29","first-page":"191","volume":"36","author":"MK Voroshilova","year":"1989","unstructured":"Voroshilova MK (1989) Potential use of nonpathogenic enteroviruses for control of human disease. Prog Med Virol 36:191\u2013202","journal-title":"Prog Med Virol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-017-3492-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3492-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T23:46:31Z","timestamp":1602632791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-017-3492-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3492"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3492-0","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}